Phylodynamics of HIV-1 from a Phase-III AIDS Vaccine Trial in North America

Author： Prez-Losada Marcos   Jobes David V.   Sinangil Faruk   Crandall Keith A.   Posada David   Berman Phillip W.  

Publisher： Oxford University Press

ISSN： 0737-4038

Source： Molecular Biology and Evolution, Vol.27, Iss.2, 2010-02, pp. : 417-425

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV-1 Subtype C Phylodynamics in the Global Epidemic

By Novitsky Vlad   Wang Rui   Lagakos Stephen   Essex Max  

Viruses, Vol. 2, Iss. 1, 2010-01 ,pp. : 33-54

MDPI

Access to resources Recommend Favorite

HLA class II diversity in HIV‐1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial

By  

TISSUE ANTIGENS, Vol. 85, Iss. 2, 2015-02 ,pp. : 117-126

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Development of a Cytomegalovirus DNA Vaccine: From Product Concept to Pivotal Phase 3 Trial

By Smith Larry R.   Wloch Mary K.   Chaplin Jennifer A.   Gerber Michele   Rolland Alain P.  

Vaccines, Vol. 1, Iss. 4, 2013-09 ,pp. : 398-414

MDPI

Access to resources Recommend Favorite

Ecological restoration of rich fens in Europe and North America: from trial and error to an evidence‐based approach

By  

BIOLOGICAL REVIEWS, Vol. 90, Iss. 1, 2015-02 ,pp. : 182-203

John Wiley & Sons Inc

Access to resources Recommend Favorite

Distribution of HIV-1 in the genomes of AIDS patients

By Tsyba L.   Rynditch A.   Boeri E.   Jabbari K.   Bernardi G.  

Cellular and Molecular Life Sciences CMLS, Vol. 61, Iss. 6, 2004-03 ,pp. : 721-726

Springer Publishing Company

Access to resources Recommend Favorite